LHU Stock Overview Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. More details
Rewards Risk Analysis LHU passed our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
LeMaitre Vascular, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for LeMaitre Vascular Historical stock prices Current Share Price US$87.50 52 Week High US$102.00 52 Week Low US$48.40 Beta 0.93 1 Month Change -14.22% 3 Month Change 10.76% 1 Year Change 71.57% 3 Year Change 96.19% 5 Year Change 171.74% Change since IPO 199.45%
Recent News & Updates
Third quarter dividend of US$0.16 announced Nov 12 Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024
Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023) Nov 01
LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024 Oct 16
Second quarter dividend of US$0.16 announced Aug 12 LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024 See more updates
Third quarter dividend of US$0.16 announced Nov 12 Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024
Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023) Nov 01
LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024 Oct 16
Second quarter dividend of US$0.16 announced Aug 12 LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024
Second quarter 2024 earnings released: EPS: US$0.53 (vs US$0.36 in 2Q 2023) Aug 02
LeMaitre Vascular, Inc. to Report Q2, 2024 Results on Aug 01, 2024 Jul 17
First quarter dividend of US$0.16 announced May 13
President & Director recently sold €353k worth of stock May 09
First quarter 2024 earnings released: EPS: US$0.44 (vs US$0.27 in 1Q 2023) May 03 LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
LeMaitre Vascular, Inc. to Report Q1, 2024 Results on May 02, 2024 Apr 21
LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024 Apr 17
Chairman & CEO recently sold €6.4m worth of stock Mar 07
Upcoming dividend of US$0.16 per share Mar 06
Fourth quarter dividend of US$0.16 announced Mar 04 LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024
Full year 2023 earnings released: EPS: US$1.36 (vs US$0.94 in FY 2022) Feb 28 LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces an Equity Buyback for $50 million worth of its shares. Feb 28
LeMaitre Vascular, Inc. to Report Q4, 2023 Results on Feb 27, 2024 Feb 14
Chairman & CEO recently sold €2.6m worth of stock Dec 13
Upcoming dividend of US$0.14 per share at 1.1% yield Nov 08
Third quarter 2023 earnings released: EPS: US$0.34 (vs US$0.25 in 3Q 2022) Nov 02
LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on November 30, 2023 Nov 02
Now 20% undervalued after recent price drop Oct 26
LeMaitre Vascular, Inc. to Report Q3, 2023 Results on Nov 01, 2023 Oct 18
Investor sentiment deteriorates as stock falls 19% Oct 13
Upcoming dividend of US$0.14 per share at 1.0% yield Aug 09 LeMaitre Vascular, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023, Fourth Quarter and Full Year Ending December 31, 2023
Second quarter 2023 earnings released: EPS: US$0.36 (vs US$0.16 in 2Q 2022) Aug 02 LeMaitre Vascular, Inc. to Report Q2, 2023 Results on Aug 01, 2023 Jul 18
Chairman & CEO recently sold €411k worth of stock May 25
Upcoming dividend of US$0.14 per share at 0.8% yield May 09
President & Director recently sold €505k worth of stock May 09 LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2023
First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2022) May 03
Insufficient new directors May 01
Senior Vice President of Operations recently sold €308k worth of stock Mar 12
Full year 2022 earnings released: EPS: US$0.94 (vs US$1.27 in FY 2021) Feb 26
LeMaitre Vascular, Inc. to Report Q4, 2022 Results on Feb 23, 2023 Feb 09
Upcoming dividend of US$0.13 per share Nov 09
Investor sentiment deteriorated over the past week Nov 03
Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.30 in 3Q 2021) Oct 29 LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022
LeMaitre Vascular, Inc. to Report Q3, 2022 Results on Oct 27, 2022 Oct 18
Lemaitre Vascular, Inc. Appoints Martha Shadan as Director Sep 24
Upcoming dividend of US$0.13 per share Aug 17
CFO, Treasurer recently sold €146k worth of stock Aug 13
CFO, Treasurer recently sold €146k worth of stock Aug 13
Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.40 in 2Q 2021) Jul 30 LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 8, 2022
LeMaitre Vascular, Inc. to Report Q2, 2022 Results on Jul 28, 2022 Jul 19
Now 21% undervalued Jun 11
First quarter 2022 earnings released: EPS: US$0.28 (vs US$0.29 in 1Q 2021) May 01
LeMaitre Vascular, Inc. to Report Q1, 2022 Results on Apr 28, 2022 Apr 16
LeMaitre Vascular, Inc., Annual General Meeting, Jun 01, 2022 Apr 15
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 26 LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022
LeMaitre Vascular, Inc. to Report Q4, 2021 Results on Feb 24, 2022 Feb 12
Now 22% undervalued after recent price drop Feb 05
Now 21% undervalued after recent price drop Jan 20
Upcoming dividend of US$0.11 per share Nov 11
Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.37 in 3Q 2020) Oct 29
Upcoming dividend of US$0.11 per share Aug 18
Second quarter 2021 earnings released: EPS US$0.40 (vs US$0.17 in 2Q 2020) Jul 31
LeMaitre Vascular, Inc. has completed a Follow-on Equity Offering in the amount of $54.5 million. Jul 15 LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Value Index
Upcoming dividend of US$0.11 per share May 11
Chairman & CEO recently sold €2.4m worth of stock May 07
First quarter 2021 earnings released: EPS US$0.29 (vs US$0.16 in 1Q 2020) May 01 Lemaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter of 2021
Insider recently sold €1.0m worth of stock Mar 16
Chairman & CEO recently sold €6.2m worth of stock Mar 10
New 90-day high: €42.80 Mar 02
Full year 2020 earnings released: EPS US$1.05 (vs US$0.91 in FY 2019) Feb 27
Revenue beats expectations Feb 27
LeMaitre Vascular, Inc. to Report Q4, 2020 Results on Feb 25, 2021 Jan 28
New 90-day high: €37.40 Jan 26 Shareholder Returns LHU DE Medical Equipment DE Market 7D 2.3% -2.2% -1.6% 1Y 71.6% -8.4% 6.8%
See full shareholder returns
Return vs Market: LHU exceeded the German Market which returned 6.8% over the past year.
Price Volatility Is LHU's price volatile compared to industry and market? LHU volatility LHU Average Weekly Movement 6.6% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: LHU has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: LHU's weekly volatility (7%) has been stable over the past year.
About the Company LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries.
Show more LeMaitre Vascular, Inc. Fundamentals Summary How do LeMaitre Vascular's earnings and revenue compare to its market cap? LHU fundamental statistics Market cap €2.00b Earnings (TTM ) €39.74m Revenue (TTM ) €204.91m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) LHU income statement (TTM ) Revenue US$213.03m Cost of Revenue US$67.45m Gross Profit US$145.58m Other Expenses US$104.26m Earnings US$41.32m
Dividends
0.7% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/25 09:20 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources LeMaitre Vascular, Inc. is covered by 22 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Michael Petusky Barrington Research Associates, Inc. Raymond Myers Benchmark Company Jan Wald Benchmark Company
Show 19 more analysts 
